Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Post by probowler900on Apr 12, 2021 10:20pm
352 Views
Post# 32982967

Portion of CIBC updated Opinion.

Portion of CIBC updated Opinion. EQUITY RESEARCH April 12, 2021
Earnings Update APHRIA INC.
Quorum Questions: Still Expect Deal To Close, Softness May Create Buying Opportunity Our Conclusion Today’s focus from management on voter encouragement suggests that there is at least some uncertainty on whether the proposed APHA-TLRY deal passes on its first attempt. We expect the biggest hurdle is attaining the required quorum for TLRY (50.1% of shares outstanding must vote). To be clear, we believe the deal eventually closes and creates an industry leader with potential for $100MM of synergies and a highly profitable entity with a leading share in Canada and Europe. We view today’s sell-off as overdone. This continues to be an industry that thrives on brick & mortar sales, and store restrictions have had a meaningful impact, which we expect to ebb by the summer. We reduce our price target to $23 (from $28), and APHA is rated Outperformer.
<< Previous
Bullboard Posts
Next >>